TIMOTHY R PEARSON
CIK 1528617 · Exec. VP, CFO · last filed 2026-06-11
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$0
Companies
5
Total Filings
28
Lifetime Open-Market Net
-$373.2K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| KRRO | Director | — | $11.61 | — | $0 | 3 | 2026-06-11 |
| CRESCENT BIOPHARMA, INC. (GLYC) Delisted | Director | 24,650 | $15.70 | $387.0K | $25.0K | 12 | 2024-05-01 |
| Ra Pharmaceuticals, Inc. (RARX) Delisted | Director | — | — | — | $0 | 4 | 2020-04-03 |
| TESARO, Inc. (TSRO) Delisted | Exec. VP, CFO | 0 | — | — | -$398.3K | 5 | 2019-01-22 |
| CATALYST HEALTH SOLUTIONS, INC. (CHSI) Delisted | EVP & Chief Financial Officer | 40,000 | — | — | $0 | 2 | 2012-02-27 |
Recent Filings · Page 2 of 3
28 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2020-04-03 | Ra Pharmaceuticals, Inc. (RARX) Delisted | Disp (D) | — | $0 | EDGAR |
| 2019-06-13 | Ra Pharmaceuticals, Inc. (RARX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-05-21 | CRESCENT BIOPHARMA, INC. (GLYC) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-01-22 | TESARO, Inc. (TSRO) Delisted | Mixed | −6,211 | -$465.8K | EDGAR |
| 2018-07-02 | Ra Pharmaceuticals, Inc. (RARX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-05-21 | CRESCENT BIOPHARMA, INC. (GLYC) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-03-05 | TESARO, Inc. (TSRO) Delisted | Mixed | +3,283 | -$141.3K | EDGAR |
| 2017-06-22 | Ra Pharmaceuticals, Inc. (RARX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-05-30 | CRESCENT BIOPHARMA, INC. (GLYC) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-03-03 | TESARO, Inc. (TSRO) Delisted | Mixed | +2,928 | -$257.0K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.